Herpes Simplex Virus Vaccine
Review covers recent progress in herpes simplex virus vaccine research
Published in Vaccine Weekly, March 12th, 2003
According to researchers from the United States, "Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause prevalent, chronic infections that have serious outcomes in some individuals. Neonatal herpes may occur when the infant traverses the cervix during maternal genital herpes. Genital herpes is a major risk factor for human immunodeficiency virus type 1 transmission."
"Considerable efforts have been made to design and test vaccines for HSV, focusing on genital infection with HSV-2," said David M. Koelle and Lawrence Corey at the University of Washington in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-03-12)
More Articles from Vaccine Weekly
- Gastroenterology Vaccine
Salmonella vaccines may fail to elicit antibody responses in immune individuals - Multiple Sclerosis Therapy
T cell vaccine shows promise in preliminary trial - DNA Vaccine
DNA vaccine partially protects murine fetuses from Chlamydophila abortus - Vaccine Safety
Meningitis risk after measles-mumps-rubella vaccination varies by vaccine strain - Cancer Therapy
Cancer vaccine one step closer - Colon Cancer Therapy
Intra-tumoral injection of CpG inhibits tumor growth in murine colon tumors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
